At OGT, we understand the challenge of analysing the wide variety of chromosomal abnormalities that are associated with CLL. Using multiple technologies to analyze single nucleotide variants (SNVs) and insertions/deletions (indels) up to large copy-number variations (CNVs), including trisomies can be time-consuming and costly.
In this webinar learn how the SureSeq™ CLL + CNV NGS Panel alleviates the burden of running multiple assays and streamlines your CLL research to deliver a comprehensive genomic profile for each CLL sample using a single NGS assay.
In addition, discover how OGT’s complimentary Interpret™ software helps you to deliver fast and accurate aberration analysis for your lab - so you get effortless translation of your data into meaningful results, every time.
SureSeq™®: For Research Use Only; Not for Diagnostic Procedures.